169 related articles for article (PubMed ID: 28123058)
41. Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study.
Pikula A; Beiser AS; DeCarli C; Himali JJ; Debette S; Au R; Selhub J; Toffler GH; Wang TJ; Meigs JB; Kelly-Hayes M; Kase CS; Wolf PA; Vasan RS; Seshadri S
Circulation; 2012 May; 125(17):2100-7. PubMed ID: 22456473
[TBL] [Abstract][Full Text] [Related]
42. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
43. Intensive Lifestyle Intervention Increases Plasma Midregional Proatrial Natriuretic Peptide Concentrations in Overweight Children.
Thomsen CF; Goharian TS; Larsen KT; Goetze JP; Andersen LB; Jeppesen JL
J Am Heart Assoc; 2021 Jul; 10(13):e020676. PubMed ID: 34180245
[TBL] [Abstract][Full Text] [Related]
44. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
[TBL] [Abstract][Full Text] [Related]
45. Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population.
Goharian TS; Goetze JP; Faber J; Andersen LB; Grøntved A; Jeppesen JL
Am J Hypertens; 2017 Jun; 30(6):561-568. PubMed ID: 28338810
[TBL] [Abstract][Full Text] [Related]
46. The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
Kube J; Ebner N; Jankowska EA; Rozentryt P; Cicoira M; Filippatos GS; Ponikowski P; Doehner W; Anker SD; von Haehling S
Int J Cardiol; 2016 Sep; 219():84-91. PubMed ID: 27288971
[TBL] [Abstract][Full Text] [Related]
47. Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study.
Nayor M; Enserro DM; Beiser AS; Cheng S; DeCarli C; Vasan RS; Seshadri S
Stroke; 2016 Feb; 47(2):383-9. PubMed ID: 26696648
[TBL] [Abstract][Full Text] [Related]
48. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
Daniels LB; Clopton P; Potocki M; Mueller C; McCord J; Richards M; Hartmann O; Anand IS; Wu AH; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Filippatos GS; Di Somma S; Ng L; Neath SX; Christenson R; Morgenthaler NG; Anker SD; Maisel AS
Eur J Heart Fail; 2012 Jan; 14(1):22-31. PubMed ID: 22140234
[TBL] [Abstract][Full Text] [Related]
49. Cardiovascular biomarker midregional proatrial natriuretic peptide during and after preeclamptic pregnancies.
Sugulle M; Herse F; Hering L; Mockel M; Dechend R; Staff AC
Hypertension; 2012 Feb; 59(2):395-401. PubMed ID: 22184318
[TBL] [Abstract][Full Text] [Related]
50. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
[TBL] [Abstract][Full Text] [Related]
51. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
[TBL] [Abstract][Full Text] [Related]
52. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study.
Seshadri S; Wolf PA; Beiser AS; Selhub J; Au R; Jacques PF; Yoshita M; Rosenberg IH; D'Agostino RB; DeCarli C
Arch Neurol; 2008 May; 65(5):642-9. PubMed ID: 18474741
[TBL] [Abstract][Full Text] [Related]
53. Effects of B-type natriuretic peptide on cardiovascular biomarkers in healthy volunteers.
Resl M; Vila G; Grimm G; Heinisch B; Riedl M; Dieplinger B; Mueller T; Luger A; Clodi M
J Appl Physiol (1985); 2015 Feb; 118(4):395-9. PubMed ID: 25539929
[TBL] [Abstract][Full Text] [Related]
54. Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.
Meyer T; Herrrmann-Lingen C; Chavanon ML; Nolte K; Pasedach CA; Binder L; Pieske B; Hasenfuss G; Wachter R; Edelmann F
Clin Res Cardiol; 2015 Jul; 104(7):574-81. PubMed ID: 25665711
[TBL] [Abstract][Full Text] [Related]
55. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
[TBL] [Abstract][Full Text] [Related]
56. Plasma MR-proANP levels are associated with carotid intima-media thickness in the general community: the KORA F4 study.
Then C; Kowall B; Lechner A; Meisinger C; Heier M; Koenig W; Peters A; Thiery J; Rathmann W; Seissler J
Atherosclerosis; 2013 Oct; 230(2):235-41. PubMed ID: 24075750
[TBL] [Abstract][Full Text] [Related]
57. The Combination of Biomarkers for Prognostication of Long-Term Outcome in Patients Treated with Mild Hypothermia After Out-of-Hospital Cardiac Arrest-A Pilot Study.
Annborn M; Nilsson F; Dankiewicz J; Rundgren M; Hertel S; Struck J; Cronberg T; Nielsen N
Ther Hypothermia Temp Manag; 2016 Jun; 6(2):85-90. PubMed ID: 26977736
[TBL] [Abstract][Full Text] [Related]
58. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
Heining L; Giesa C; Ewig S
Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
[TBL] [Abstract][Full Text] [Related]
59. Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study.
Conijn MM; Kloppenborg RP; Algra A; Mali WP; Kappelle LJ; Vincken KL; van der Graaf Y; Geerlings MI;
Stroke; 2011 Nov; 42(11):3105-9. PubMed ID: 21868739
[TBL] [Abstract][Full Text] [Related]
60. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
